The post Ethereum Foundation Sponsors SEAL: ETH Security appeared on BitcoinEthereumNews.com. Ethereum Foundation and SEAL Partnership The Ethereum Foundation isThe post Ethereum Foundation Sponsors SEAL: ETH Security appeared on BitcoinEthereumNews.com. Ethereum Foundation and SEAL Partnership The Ethereum Foundation is

Ethereum Foundation Sponsors SEAL: ETH Security

Ethereum Foundation and SEAL Partnership

The Ethereum Foundation is supporting efforts to track and neutralize crypto drainers and social engineering attackers targeting Ethereum users by taking on sponsorship of the crypto security organization Security Alliance (SEAL). SEAL announced that it has launched the “Trillion Dollar Security” initiative with the foundation; the foundation is sponsoring a security engineer who will work with SEAL’s intelligence team.


Source: Security Alliance

SEAL protects crypto participants by sharing threat intelligence, incident response, and providing legal protection to white-hat hackers. The Ethereum Foundation noted that SEAL has done significant work against attacks. According to ScamSniffer data, drainer and phishing attackers have stolen nearly 1 billion dollars over the years, but with SEAL and other efforts, this figure dropped to a record low of 84 million dollars in 2025.

ETH Security Dashboard Details

With SEAL, the foundation has launched a dashboard that tracks Ethereum’s security across six dimensions: user experience, smart contracts, infrastructure, consensus protocol, monitoring, and social layer; 8-29 risk controls are monitored in each dimension. This strengthens the proactive protection of the ETH ecosystem.


Security assessment of smart contracts on Ethereum. Source: Trillion Dollar Security

SEAL stated that the Ethereum Foundation collaboration is the first step and invited other crypto ecosystems to similar sponsorships. This development may increase confidence in terms of ETH detailed analysis.

ETH Technical Outlook (February 10, 2026)

ETH price 2.049,87 USD (-%2,01 24h). RSI 31,32 (Oversold), downtrend, Supertrend Bearish. EMA 20: 2.414,71.

  • Supports: S1 2.060,57 (79/100 ⭐ Strong, -%0,50), S2 1.747,80 (71/100 ⭐ Strong, -%15,61)
  • Resistances: R1 2.147,73 (75/100 ⭐ Strong, +%3,71), R2 2.575,36 (73/100 ⭐ Strong, +%24,35)

Be cautious with ETH futures; security news may affect volatility. ETH spot analysis is recommended.

Market Analyst: Sarah Chen

Technical analysis and risk management specialist

This analysis is not investment advice. Do your own research.

Source: https://en.coinotag.com/ethereum-foundation-sponsors-seal-eth-security

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$2,015.81
$2,015.81$2,015.81
-2.16%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26